JCIA
RIGL icon

Jackson Creek Investment Advisors’s Rigel Pharmaceuticals RIGL Stock Holding History

Jackson Creek Investment Advisors’s Portfolio RIGL Stock Details RIGL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$321K Sell
11,883
-11
-0.1% -$370 0.09% 278
2025
Q4 		$509K Sell
11,894
-169
-1% -$6.37K 0.15% 201
2025
Q3 		$342K Sell
12,063
-5,989
-33% -$179K 0.1% 253
2025
Q2 		$338K Sell
18,052
-19,993
-53% -$379K 0.09% 286
2025
Q1 		$684K Buy
+38,045
New +$772K 0.22% 208

Other funds holding RIGL

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
AC
Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
LSV Asset Management
LSV Asset Management Chicago, Illinois $46.4B AUM 27.74% 1-Year Est. Return
Marshall Wace
Marshall Wace London, United Kingdom $100B AUM 35.1% 1-Year Est. Return
American Century Companies
American Century Companies Kansas City, Missouri $194B AUM 35% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Jackson Creek Investment Advisors's RIGL Position: Q1 2026 in Review

Jackson Creek Investment Advisors reduced its Rigel Pharmaceuticals (RIGL) stake by 0.09% in Q1 2026, selling an estimated $370 and leaving 11,883 shares worth $321K. The position accounts for 0.09% of the portfolio, ranked #278.

Jackson Creek Investment Advisors first reported a position in RIGL in Q1 2025 and has held it in 5 quarters since. The position peaked at $684K in Q1 2025. 159 funds tracked by Wall St. Rank hold RIGL as of Q1 2026.

  • Jackson Creek Investment Advisors held 11,883 shares of Rigel Pharmaceuticals worth $321K as of Q1 2026.
  • Jackson Creek Investment Advisors sold 11 Rigel Pharmaceuticals shares in Q1 2026, an estimated $370.
  • Rigel Pharmaceuticals made up 0.09% of Jackson Creek Investment Advisors's portfolio in Q1 2026, its #278 holding.
  • Jackson Creek Investment Advisors first reported a position in Rigel Pharmaceuticals in Q1 2025 and has held it in 5 quarters since.
  • Jackson Creek Investment Advisors's Rigel Pharmaceuticals position peaked at $684K in Q1 2025.
  • 159 funds tracked by Wall St. Rank held Rigel Pharmaceuticals as of Q1 2026.

Based on Jackson Creek Investment Advisors's 13F filing for Q1 2026, filed 5 May 2026.